Opportunities for the repurposing of PARP inhibitors for the therapy of non‐oncological diseasesNathan A. Berger, Csaba Szabó, Alberto Chiarugi et al.|British Journal of Pharmacology|2017Cited by 210
Increase in the Content of Quinolinic Acid in Cerebrospinal Fluid and Frontal Cortex of Patients with Hepatic FailureFlavio Moroni, N.P.V. Nair, Giovanni Lombardi et al.|Journal of Neurochemistry|1986Cited by 92